IDH1 and neoplasm: Since the migration and proliferation of post‐surgical residual tumor cells are responsible for tumor recurrence, the GOx@MnCaP@fibrin gel has potential to inhibit IDH1 (R132H) tumor recurrence, which was demonstrated on a subcutaneous U87 tumor surgical resection model in this study.